NewsRoom Articles - Page 67 of 236

WednesdayMar 06, 2024 10:30 am

Despite Slowing Growth, eCommerce Sales Reach Record Level in US

Latest figures from the Department of Commerce show that the slowest growth in e-commerce sales was recorded during the last quarter of 2023. This is in comparison to the previous quarter and 2022’s last quarter. In the third quarter of 2023, growth in ecommerce sales stood at 7.8% while that of 2022’s last quarter was 7.7%. On a positive note, Q4 sales in the United States hit $324.8 billion, according to an analysis conducted by Digital Commerce 360. This figure represented more than 7% growth when compared with figures from the last quarter of 2022. Data from the department shows…

TuesdayMar 05, 2024 9:45 am

Sigyn Therapeutics Inc. (SIGY) Therapeutic Candidates to Overcome Limitations in Healthcare

Sigyn Therapeutics is developing four medical device candidates – Sigyn Therapy(TM), ChemoPrep(TM), ChemoPure(TM), and ImmunePrep(TM) – designed to overcome current therapeutic limitations in healthcare Sigyn Therapy(TM), the company’s lead product candidate, is a single-use disposable device to treat life-threatening inflammatory conditions that are beyond the reach of drugs ChemoPrep(TM) is designed to optimize the tumor-site delivery of chemotherapy, while ChemoPure(TM) intends to reduce the toxicity of chemotherapy by sweeping off-target chemotherapy out of the bloodstream ImmunePrep(TM) is designed to reduce the presence of circulating drug decoys that interfere with the delivery of immunotherapeutic antibodies to treat cancer Medical technology company Sigyn…

MondayMar 04, 2024 11:00 am

Study Links Parkinson’s Onset in Rocky Mountain Area to Agricultural Pesticides

Preliminary research has found that herbicides and pesticides used in farming may be associated with Parkinson’s disease. For their research, the investigators reviewed records from more than 20 million individuals obtained from Medicare. The objective of the researchers was to calculate the rate of Parkinson’s disease for different regions in the country. They also examined possible links between the use of more than 60 pesticides and rates of Parkinson’s disease. The author of the study, Brittany Krzyzanowski, explained that the team of investigators utilized geographic techniques to study the disorder’s rates then compared their findings to regional levels of herbicide…

MondayMar 04, 2024 10:30 am

Astiva Health Inc. CEO Featured Podcast Guest, Talks Commitment to Help Patients Enjoy ‘Active, Healthy and Meaningful’ Lives

In addition to providing full medical-care prescription drugs, Astiva focuses on providing rich supplemental benefits to enrollees CEO explains that “effective healthcare hinges largely on patient involvement” Astiva’s recent expansion is a crucial step in extending invaluable benefits and commitment to quality healthcare to a growing, diverse population Astiva Health CEO Dr. Tri Nguyen was the featured guest in a recent Bell2Bell Podcast release (https://ibn.fm/0Rufk). During the podcast, Nguyen talked provided an in-depth look at how Astiva Health is reshaping healthcare delivery, including an overview of the company’s commitment to patient involvement in healthcare and highlights the company’s innovative strategies in offering comprehensive…

FridayMar 01, 2024 11:30 am

A Comparison Between ALS, Parkinson’s Disease

Parkinson’s disease and amyotrophic lateral sclerosis (ALS) are conditions that affect an individual’s nervous system and brain. Both conditions also cause tremors during the early stages, which can affect an individual’s movement. Despite their similarities, however, the conditions require different treatments to manage their symptoms. Below, we look at the similarities and differences between ALS and Parkinson’s disease. What is Parkinson’s disease? This condition destroys cells in the basal ganglia, which makes it hard for individuals to control their movements. Data from the Parkinson’s Foundation shows that about 90,000 individuals are diagnosed with this condition annually in America. This condition’s…

WednesdayFeb 28, 2024 9:45 am

Siteman Cancer Center Starts Offering Novel Cell-Based Immunotherapy Against Melanoma

Patients with melanoma may soon be able to access a new immunotherapy that was recently approved by the U.S. Food and Drug Administration (FDA). The cell-based treatment, which was developed by Iovance Therapeutics, will first be administered by physicians at the Siteman Cancer Center in Washington University before it can be commercialized under the name Amtagvi. The tumor-infiltrating lymphocyte immunotherapy has been designed for the treatment of metastatic melanoma, which is a skin cancer that has spread to other parts of the body. The treatment, called lifileucel, has been designed specifically for patients suffering from this particular cancer whose tumor…

TuesdayFeb 27, 2024 12:00 pm

Astiva Health Inc. Championing Culturally Sensitive Healthcare for Aging Asian American Population

By 2060, the older Asian population in the U.S. is expected to reach 8.5 million, making up 9% of the country's elderly demographic, signaling a significant increase from 4% in 2014 Astiva Health is leading the charge in creating essential healthcare solutions tailored for this expanding demographic, demonstrating a deep understanding of their unique healthcare needs Astiva Health has introduced groundbreaking programs, including language-specific healthcare services and wellness initiatives, specifically designed for the diverse aging Asian American community Astiva Health is working serve the Asian American community, which is undergoing a considerable demographic shift, with a growing segment of the…

TuesdayFeb 27, 2024 11:15 am

Astrotech Corp. (NASDAQ: ASTC) Reports 512% Jump in YTD Revenue

Astrotech reported financial results for the quarter ended December 31, 2023, recording year-to-date revenue of $1,540,000 The company attributed the growth to the successful fulfillment of two significant purchase orders for the TRACER 1000(TM), the world’s first mass spectrometer-based explosive trace detectors (“ETD”), to customers in Romania Astrotech is focused on commercializing its innovative platform mass spectrometry technology through its wholly owned subsidiaries 1st Detect Corp., AgLAB Inc., Pro-Control Inc., and BreathTech Corp. The company and its subsidiaries are positioned to capitalize on burgeoning markets, including the global mass spectrometry market, expected to grow from an estimated $6.77 billion in…

TuesdayFeb 27, 2024 10:30 am

Sigyn Therapeutics Inc. (SIGYD) Completes Reverse Stock Split, Releases Year-End Financial Report for 2023

Sigyn's common stock, temporarily trading under the ticker symbol "SIGYD", is set to revert back to its historic symbol "SIGY" on February 29, 2024. The company, as part of its 2023 Year-End Report, summarized its development of medical technologies that target to overcome clearly defined limitations in global health. During 2023, Sigyn expanded its line-up of medical technologies designed to enhance the benefit of cancer therapies. The company’s cancer treatment pipeline now includes ImmunePrep(TM), ChemoPrep(TM), and ChemoPure(TM). The company believes the successful clinical advancement of Sigyn Therapy(TM) to treat pathogen-associated conditions beyond the reach of drugs, may offer a…

MondayFeb 26, 2024 9:30 am

Study Shows Troops That Sustain Serious Brain Injuries Have Higher Risk of Brain Cancer

Figures show that brain cancer occurs in less than 1% of the population in America. At least one-third of individuals diagnosed with primary brain cancer tumors survive for at least five years. Those with glioblastoma, a common type of brain cancer, have about a 14% chance of living an additional five years. This is dependent on the age of diagnosis, however. While what causes brain cancer is still unknown, scientists theorize that exposure to ionized radiation may be linked to this illness. Now, new research has found that veterans who experience head injuries have a heightened risk of developing brain…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Despite Slowing Growth, eCommerce Sales Reach Record Level in US

Sigyn Therapeutics Inc. (SIGY) Therapeutic Candidates to Overcome Limitations in Healthcare

Study Links Parkinson’s Onset in Rocky Mountain Area to Agricultural Pesticides

Astiva Health Inc. CEO Featured Podcast Guest, Talks Commitment to Help Patients Enjoy ‘Active, Healthy and Meaningful’ Lives

A Comparison Between ALS, Parkinson’s Disease

Siteman Cancer Center Starts Offering Novel Cell-Based Immunotherapy Against Melanoma

Astiva Health Inc. Championing Culturally Sensitive Healthcare for Aging Asian American Population

Astrotech Corp. (NASDAQ: ASTC) Reports 512% Jump in YTD Revenue

Sigyn Therapeutics Inc. (SIGYD) Completes Reverse Stock Split, Releases Year-End Financial Report for 2023

Study Shows Troops That Sustain Serious Brain Injuries Have Higher Risk of Brain Cancer

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search